Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same.
- Author:
Vishal SAHU
1
;
Lokesh NIGAM
;
Vertica AGNIHOTRI
;
Abhishek GUPTA
;
Shashank SHEKHAR
;
Naidu SUBBARAO
;
Suman BHASKAR
;
Sharmistha DEY
Author Information
- Publication Type:Original Article
- Keywords: Head and neck squamous cell carcinoma; Surface plasmon resonance; p38 isoforms; Peptide inhibitor; Serum; Molecular docking
- MeSH: Adenosine Triphosphate; Carcinoma, Squamous Cell*; Cytokines; Epithelial Cells*; Follow-Up Studies; Head*; Humans; Models, Molecular; Neck*; p38 Mitogen-Activated Protein Kinases; Protein Isoforms*; Protein Kinases; Surface Plasmon Resonance
- From:Cancer Research and Treatment 2019;51(1):313-325
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The p38 mitogen-activated protein kinase (MAPKs) play a crucial role in the production of pro-inflammatory cytokines and over-expression of it increase cytokines which promote cancer. Among four isoforms, p38α has been well studied in head and neck squamous cell carcinoma (HNSCC) and other cancers as a therapeutic target. p38δ has recently emerged as a potential disease-specific drug target. Elevated serum p38α level in HNSCC was reported earlier from our lab. This study aims to estimate the levels of p38 MAPK-isoforms in the serum of HNSCC and design peptide inhibitor targeting the same. MATERIALS AND METHODS: Levels of p38 MAPK isoforms in the serum of HNSCC and healthy controls were quantified by surface plasmon resonance technology. The peptide inhibitor for p38 MAPK was designed by molecular modeling using Grid-based Ligand Docking with Energetics tools and compared with known specific inhibitors. RESULTS: We have observed highly elevated levels of all four isoforms of p38 MAPK in serum of HNSCC patients compared to the control group. Further, serum p38α, p38β, and p38δ levels were down regulated after therapy in follow-up patients, while p38γ showed no response to the therapy. Present study screened designed peptide WFYH as a specific inhibitor against p38δ. The specific inhibitor of p38δ was found to have no effect on p38α due to great structural difference at ATP binding pocket. CONCLUSION: In this study, first time estimated the levels of p38 MAPK isoforms in the serum of HNSCC. It can be concluded that p38 MAPK isoforms can be a diagnostic and prognostic marker for HNSCC and p38δ as a therapeutic target.
